Skip to main content
Jeff Wang, MD, Pathology, Chesterfield, MO

JeffFilbertWangMD

Pathology Chesterfield, MO

Cytopathology, Anatomic Pathology, Clinical Pathology

Assistant Professor, Pathology & Immunology, Washington University School of Medicine

Are you Dr. Wang?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 6 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    1205 Wildhorse Meadows Dr
    Chesterfield, MO 63005
    Phone+1 402-598-2672

Summary

  • Dr. Jeff Wang, MD is a board certified pathologist in Chesterfield, Missouri. He is currently licensed to practice medicine in Missouri, Florida, and Illinois. He is affiliated with Springfield Memorial Hospital and is an Assistant Professor at Washington University School of Medicine.

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Cytopathology, 2010 - 2011
  • Creighton University School of Medicine (Omaha)
    Creighton University School of Medicine (Omaha)Residency, Pathology-Anatomic and Clinical, 2006 - 2010
  • Medical College of Nanchang University
    Medical College of Nanchang UniversityClass of 1989

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2014 - 2026
  • FL State Medical License
    FL State Medical License 2015 - 2019
  • MO State Medical License
    MO State Medical License 2011 - 2018
  • NE State Medical License
    NE State Medical License 2010 - 2018
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of Pathology Cytopathology

Publications & Presentations

PubMed

Press Mentions

  • SeaSpine Reports Record Revenue, Driven by 16% U.S. Spinal Implants Growth
    SeaSpine Reports Record Revenue, Driven by 16% U.S. Spinal Implants GrowthOctober 29th, 2019